Harry E. Gruber

DR. HARRY E. GRUBER is President, Chief Executive Officer and Chairman
of the Board of Directors of Kintera, Inc. Dr. Gruber, co-founded
Kintera and has served as its President, Chief Executive Officer and
Chairman of the Board of Directors since 2000. Prior to founding
Kintera, Dr. Gruber co-founded INTERVU Inc., a publicly held Internet
video and audio delivery company, where he served as the Chief Executive
Officer from 1995 to 2000, and which was acquired by Akamai
Technologies, Inc., in 2000. In 1986, Dr. Gruber founded Gensia
Pharmaceuticals, Inc. (now known as SICOR Inc., which was acquired by
Teva Pharmaceutical Industries Ltd.) and served as the Vice President,
Research of the publicly held biotechnology firm from its inception
until 1995. Dr. Gruber was also the Founder of two additional public
companies: Aramed, Inc., a central nervous system drug discovery
company, and Viagene, Inc., a gene therapy company, which was acquired
by Chiron Corporation. After completing his training in Internal
Medicine, Rheumatology and Biochemical Genetics, Dr. Gruber served on
the faculty at the University of California, San Diego from 1977 until
1986. In addition to serving as Chairman of the Board of Directors of
Kintera, Dr. Gruber currently is a member of the Board of Overseers of
the School of Arts and Sciences of the University of Pennsylvania, a
member of the University of Pennsylvania Medical School Medical Alumni
Leadership Council, a Board member of the San Diego Regional Chamber of
Commerce Foundation, San Diego and an Advisory Board member of KPBS and
previously served on the UCSD Foundation Board of Directors where he
headed the Development Committee. He is the author of over 100 original
scientific articles and an inventor of 33 issued and numerous pending
patents. Dr. Gruber holds a BA and an MD from the University of
Pennsylvania.